Atlantic Cancer Consortium
Officially designated as a member of the Marathon of Hope Cancer Centres Network (MOHCCN) in December 2022, the Atlantic Cancer Consortium (ACC) shares the MOHCCN vision to unite Canada to cure cancer. We are aligned with the MOHCCN mission to create a national network that applies world-leading science to cancer care, with a focus on precision medicine. We have rallied our region’s leading cancer researchers, institutions and care facilities to unite around this vision to enhance inter-institutional and inter-provincial cancer research collaboration, to increase cancer research capacity and productivity and to train the next generation of ACC cancer researchers in precision medicine.
As the smallest region joining the MOHCCN, Atlantic Canada has always taken a regionally collaborative approach to cancer research. Assembling our collective critical mass has been essential to creating a thriving cancer research environment. With the MOHCCN, the ACC is excited to contribute to the advancement of cancer research nationally through the engagement with rural and underserved communities to deliver precision oncology opportunities, engagement with Indigenous communities to develop a framework for collaboration, and the implementation of precision medicine in the clinical setting, immunology, metabolism, and biomarkers.
Patient Advisory Committee
In addition to supporting cutting edge research, the ACC is creating an Atlantic Canada-wide community-based Advisory Committee on cancer research and public engagement. This committee will advise and work on research and public engagement priorities of people affected by cancer in Atlantic Canada. It will also support the activities of the researchers of the Marathon of Hope – Atlantic Cancer Consortium (MoH ACC). Learn more about this initiative, here.
Partners
-
Member
-
Member
-
Member
-
Member
-
Member
-
Member
Projects
-
TFRI Atlantic Canada Myeloma Cohort
Key Researchers
Consortium Leadership
-
Sherri
Consortium LeaderMOHCCN Steering CommitteeWorking Group Member
Christian -
Robin
Consortium LeaderMOHCCN Steering CommitteeWorking Group Member
Urquhart -
Anthony
Consortium Leader
Reiman -
Acar
Institutional LeadResearcher
Cenk -
Thomas
Institutional LeadResearcherWorking Group Member
Belbin -
Sidney
Institutional LeadWorking Group Member
Croul -
Daniel
Institutional LeadWorking Group Member
Gaston -
Alexi
Institutional LeadWorking Group Member
Surrette -
John
Institutional LeadWorking Group Member
Thoms -
J. Patrick
Institutional Lead
Murphy
Project Management Team
-
Neetu
Project Manager
Singh -
Eileen
Project Manager
Bruce
Related News
-
Meet the Team Canada of Cancer Research: A Q&A with Dr. Rodney Ouellette
Meet Dr. Rodney Ouellette, Senior Researcher and Founder of the Atlantic Cancer Research Institute in Moncton, New Brunswick Dr. Rodney Ouellette played a pivotal role in the establishment of the Terry Fox Research Institute and its Marathon of Hope Cancer Centres Network, and more than 40 years after he first heard Terry s... -
Reflecting on the Year of Data Acceleration: A Network update by Dr. André Veillette
Dr. André Veillette, Executive Director of the Marathon of Hope Cancer Centres Network, provides an update on the Year of Data Acceleration. Dr. André Veillette, Executive Director of the Marathon of Hope Cancer Centres Network, provides an update on the Year of Data Acceleration. -
7 ways Canadians will benefit from the Marathon of Hope Cancer Centres Network
Accelerating precision oncology lies at the heart of our plan to provide new hope to patients across Canada. By working together towards this goal, our network will help make significant progress towa... -
Celebrating exciting milestones for our Network!
"We now have over 3,000 full genomes profiled as part of this initiative, nearly 700 of which already have their corresponding clinical data."